Balyasny Asset Management Portfolio holdings

Balyasny Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Balyasny Asset Management held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Balyasny Asset Management opened a new position in Lowe's Companies worth $86M.

• Balyasny Asset Management's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
• Balyasny Asset Management added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
• Balyasny Asset Management's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
• Balyasny Asset Management fully exited American International in Q1 2020, selling an estimated $193M.
• Balyasny Asset Management's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
• Balyasny Asset Management opened 583 new positions and closed 598 in Q1 2020.
• Balyasny Asset Management's portfolio value fell 50% quarter-over-quarter to $8.43B.

Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.